The Plasticity of CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup>CD127<sup>low</sup> T Cells in Patients with Metastatic Renal Cell Carcinoma in the Course of Interferon-Alpha Immunotherapy

<div>Foxp3 expression in peripheral blood of patients with mRCC in the course of IFN-<i>α</i> immunotherapy.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: The Plasticity of CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup>CD127<sup>low</sup> T Cells in Patients with Metastatic Renal Cell Carcinoma in the Course of Interferon-Alpha Immunotherapy 

Figure 4 | The Plasticity of CD4+CD25+FOXP3+CD127low T Cells in Patients with Metastatic Renal Cell Carcinoma in the Course of Interferon-Alpha Immunotherapy 